Shining a Spotlight on Nucleic Acid-Based Therapeutics
Further development of nucleic acid-based therapeutics has been accelerated by the recent success of mRNA vaccines.
Scaling Up Cell Therapies Capacity
Outsourcing partners are ready to fill the market need for greater cell therapies capacities.
908 Devices and CPI Partner to Optimize Cell Culture Media for Improved Process Control
908 Devices and CPI have formed a collaboration to optimize cell culture media to allow for improved process control.
Lonza and Integral Molecular Enter Biotherapeutics De-Risking Collaboration
Lonza and Integral Molecular will collaborate to better assess the risks of off-target binding of biologic drug candidates.
MilliporeSigma’s ZooMAb Antibodies Earn ACT Label from My Green Lab
MilliporeSigma’s ZooMAb antibodies have been recognized for their low environmental impact by My Green Lab.
Standard BioTools Launches Hyperion+ Imaging System
Standard BioTools’ new Hyperion+ Imaging System can process more samples and has lower limits of detection than their current product.
Bio-Rad’s Three New Fluorescent Dyes are Intended to Enhance Multiplex Flow Cytometry
Bio-Rad Laboratories introduces three new fluorescent dyes under the StarBright product range to support multicolor flow cytometry panels.
Otsuka Pharmaceutical and Osaka University Enter Exclusive License Agreement
Otsuka Pharmaceutical and Osaka University have entered an exclusive license agreement on a new anti-tumor antibody.
Thermo Fisher Scientific Launches New GMP-manufactured Cas9 Protein
Thermo Fisher Scientific has launched its first GMP-manufactured Cas9 protein for clinical genome editing research.
VectorBuilder to Expand with $500 Million Gene Delivery Research and Manufacturing Campus
VectorBuilder will expand with the construction of new $500 million Gene Delivery Research and Manufacturing Campus in Guangzhou, China.
University Hospital Hamburg-Eppendorf Leads Trial to Explore Personalized Medicine in COVID-19
Biomarker-guided trial led by University Hospital Hamburg-Eppendorf (UKE) opens new avenues for personalized medicine for treatment of COVID-19.
